Clinical validation of a quantitative HIV-1 DNA droplet digital PCR assay: Applications for detecting occult HIV-1 infection and monitoring cell-associated HIV-1 dynamics across different subtypes in HIV-1 prevention and cure trials.

BACKGROUND In HIV-1-exposed infants, nucleic acid testing (NAT) is required to diagnose infection since passively transferred maternal antibodies preclude antibody testing. The sensitivity of clinical NAT assays is lowered with infant antiretroviral prophylaxis and, with empiric very early antiretroviral treatment of high-risk infants, thereby impacting early infant diagnosis. Similarly, adult HIV-1 infections acquired under pre-exposure prophylaxis may occur at low levels, with undetectable plasma viremia and indeterminate antibody tests, for which HIV-1 DNA testing maybe a useful adjunct. Cell-associated HIV-1 DNA concentrations are also used to monitor HIV-1 persistence in viral reservoirs with relevance to HIV-1 cure therapeutics, particularly in perinatal infections. OBJECTIVES We clinically validated an HIV-1 DNA quantitative assay using droplet digital PCR (ddPCR), across different HIV-1 subtypes. STUDY DESIGN The analytical sensitivity and specificity of an HIV-1 DNA ddPCR assay was determined using serial dilutions of a plasmid containing HIV-1 LTR-gag spiked into peripheral blood mononuclear cells (PBMCs), with MOLT-4 cells or PBMCs infected with different HIV-1 subtypes (A, B and C), and U1 cells spiked into PBMCs. Inter- and intra-run variability were used to determine assay precision. RESULTS The HIV-1 LTR-gag ddPCR assay was reliable and reproducible, and exhibited high analytical specificity with sensitivity to near single copy level, across multiple HIV-1 subtypes, and a limit of detection of 4.09 copies/million PBMCs. CONCLUSIONS This assay has applications for detecting occult HIV-1-infection in the setting of combination and long-acting regimens used for HIV-1 prevention, across different HIV-1 subtypes, in infants and adults, and in HIV-1 cure interventions.

• Publication year

  2020

• Venue

  Journal of Clinical Virology

• Publication date

  2020-09-30

• Fields of study

  Medicine

• Identifiers
  DOI 10.1101/2020.09.29.20200154PMID 33930698PMCID PMC8212401
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Capitalizing on Post-exposure ARV Prophylaxis to Restrict Seeding of the HIV Reservoir.

  2020cited by this paper
• Continuous prophylactic ARV/ART since birth reduces seeding and persistence of the viral reservoir in vertically HIV-infected children.

  2020cited by this paper
• The HIV-1 antibody response: a footprint of the viral reservoir in children vertically infected with HIV.

  2020cited by this paper
• Kinetics of plasma HIV rebound in the era of modern antiretroviral therapy.

  2020cited by this paper
• Measuring the Success of HIV-1 Cure Strategies

  2020cited by this paper
• HIV-1 DNA decay dynamics in early treated individuals: practical considerations for clinical trial design

  2020cited by this paper
• Recommendations for measuring HIV reservoir size in cure-directed clinical trials

  2020cited by this paper
• Challenges in the Early Infant HIV Diagnosis and Treatment Cascade.

  2020cited by this paper
• Long-Acting HIV Drugs for Treatment and Prevention.

  2019cited by this paper
• A novel quantitative approach for measuring the reservoir of latent HIV-1 proviruses

  2019cited by this paper
• HIV‐1 DNA decay is faster in children who initiate ART shortly after birth than later

  2019cited by this paper
• Early antiretroviral therapy in neonates with HIV-1 infection restricts viral reservoir size and induces a distinct innate immune profile

  2019cited by this paper
• Rapid decline of HIV-1 DNA and RNA in infants starting very early antiretroviral therapy may pose a diagnostic challenge

  2018cited by this paper
• Human Immunodeficiency Virus (HIV)-Antibody Repertoire Estimates Reservoir Size and Time of Antiretroviral Therapy Initiation in Virally Suppressed Perinatally HIV-Infected Children.

  2018cited by this paper
• Impact of the time to achieve viral control on the dynamics of circulating HIV-1 reservoir in vertically infected children with long-term sustained virological suppression: A longitudinal study

  2018cited by this paper
• HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study

  2017cited by this paper
• Human Immunodeficiency Virus Type 1 DNA Decay Dynamics With Early, Long-term Virologic Control of Perinatal Infection

  2017cited by this paper
• HIV integration sites in latently infected cell lines: evidence of ongoing replication

  2017cited by this paper
• Droplet Digital PCR versus qPCR for gene expression analysis with low abundant targets: from variable nonsense to publication quality data

  2017cited by this paper
• Defective proviruses rapidly accumulate during acute HIV-1 infection

  2016cited by this paper
• ddpcRquant: threshold determination for single channel droplet digital PCR experiments

  2015cited by this paper
• Rapid viral rebound after 4 years of suppressive therapy in a seronegative HIV-1 infected infant treated from birth.

  2015cited by this paper
• Influence of age at virologic control on peripheral blood human immunodeficiency virus reservoir size and serostatus in perinatally infected adolescents.

  2014cited by this paper
• Optimising droplet digital PCR analysis approaches for detection and quantification of bacteria: a case study of fire blight and potato brown rot

  2014cited by this paper
• Low copy target detection by Droplet Digital PCR through application of a novel open access bioinformatic pipeline, ‘definetherain’

  2014cited by this paper
• Reduced markers of HIV persistence and restricted HIV-specific immune responses after early antiretroviral therapy in children

  2014cited by this paper
• HIV-1 DNA decay dynamics in blood during more than a decade of suppressive antiretroviral therapy.

  2014cited by this paper
• Absence of detectable HIV-1 viremia after treatment cessation in an infant.

  2013cited by this paper
• Highly Precise Measurement of HIV DNA by Droplet Digital PCR

  2013influential reference
• False-negative post-18-month confirmatory HIV tests in HIV DNA PCR-positive children: a retrospective analysis

  2012cited by this paper
• High-Throughput Droplet Digital PCR System for Absolute Quantitation of DNA Copy Number

  2011cited by this paper
• Difficulties in assigning human immunodeficiency virus-1 infection and seroreversion status in a cohort of HIV-exposed in children using serologic criteria established by the Centers for Disease Control and Prevention.

  1994cited by this paper
• [HIV infection in infants and children].

  1993cited by this paper
• Laboratory methods for early detection of human immunodeficiency virus type 1 in newborns and infants

  1992cited by this paper
• Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone.

  1989cited by this paper

• ART-free HIV-1 remission in children with in-utero HIV-1 after very early ART (IMPAACT P1115): a multicentre, open-label, phase 1/2 proof-of-concept study.

  2025cites this paper
• Deactivated Cas9-Engineered Magnetic Micromotors toward a Point-of-Care Digital Viral RNA Assay.

  2025cites this paper
• Duplex digital PCR assay on microfluidic chamber arrays for total HIV DNA reservoir quantification in persons with HIV

  2025cites this paper
• Characterization of HIV-1 Reservoirs in Children and Adolescents: A Systematic Review and Meta-analysis toward Pediatric HIV Cure.

  2024cites this paper
• The Significance and Importance of dPCR, qPCR, and SYBR Green PCR Kit in the Detection of Numerous Diseases.

  2024cites this paper
• Correlative Imaging to Detect Rare HIV Reservoirs and Associated Damage in Tissues.

  2024cites this paper
• HIV DNA Levels in Persons Who Acquired HIV in the Setting of Long-Acting Cabotegravir for HIV Prevention: Analysis of Cases from HPTN 083 and 084

  2024cites this paper
• Validation of digital droplet PCR assays for cell-associated HIV-1 DNA, HIV-1 2-LTR circle, and HIV-1 unspliced RNA for clinical studies in HIV-1 cure research.

  2023cites this paper
• HIV-1 remission and possible cure in a woman after haplo-cord blood transplant.

  2023cites this paper
• Use of laboratory-developed assays in global HIV-1 treatment-monitoring and research

  2023cites this paper
• Recombinant Virus Quantification Using Single-Cell Droplet Digital PCR: A Method for Infectious Titer Quantification

  2023cites this paper
• Current HIV/SIV Reservoir Assays for Preclinical and Clinical Applications: Recommendations from the Experts 2022 NIAID Workshop Summary

  2023cites this paper
• HIV-1 reservoir size after neonatal antiretroviral therapy and the potential to evaluate antiretroviral-therapy-free remission (IMPAACT P1115): a phase 1/2 proof-of-concept study.

  2023cites this paper
• Age at ART initiation and proviral reservoir size in perinatal HIV-1 infection: considerations for ART-free remission

  2023cites this paper
• Accuracy of real-time PCR and digital PCR for the monitoring of total HIV DNA under prolonged antiretroviral therapy

  2022cites this paper
• Image Segmentation and Quantification of Droplet dPCR Based on Thermal Bubble Printing Technology

  2022cites this paper
• Electrochemical biosensor based on topological insulator Bi2Se3 tape electrode for HIV-1 DNA detection

  2022cites this paper